50-year-old with a growth extending over the cornea
Patient will present as → a 65-year-old male Hispanic farmworker who is brought to you by his concerned wife. She reports he has had this "thing" on his left eye for years and refuses to seek care. He denies pain or discharge from the affected eye. Physical exam reveals an elevated, superficial, fleshy, triangular-shaped fibrovascular mass in the inner corner/nasal side of the left eye.
To watch this and all of Joe Gilboy PA-C's video lessons you must be a member. Members can log in here or join now.
A pterygium is a triangular wedge of fibrovascular conjunctival tissue over the medial or lateral aspect of the cornea approaching the pupil
- Pterygium is associated with increased sun (UV) exposure and climates where there is wind, sand, and dust
- The most common symptoms caused by pterygium are redness and irritation. Visual impairment is less common
- Pterygium oscillates between active and inactive
- Pterygium, when active (marked clinically by redness and localized thickening), can grow over a period of several months to years
- When inactive (white and flat), pterygium may remain static for decades with no measurable increase in size or clinical significance.
- Differentiate from pinguecula, which is a yellow, elevated nodule on the nasal side of the eye (fat and protein) that does not grow
The diagnosis of pterygium is clinical and made by the classic appearance of a wedge-shaped growth extending onto the cornea
- Look for an elevated, superficial, fleshy, triangular-shaped “growing” fibrovascular mass
- Pterygium is also more likely to be bilateral than unilateral
Patients with a small pterygium can be treated symptomatically for redness and irritation with artificial tears or other ocular lubricants
- Only surgically remove when vision or eye movement is affected
- Exposure to ultraviolet (UV) light is an important risk for recurrence - Lubrication and protection with a hat and/or UV-blocking spectacles that fit closely, wrap-around, or have side shields can prevent recurrence
- Induced astigmatism that causes visual impairment
- Opacity in the visual axis
- Documented growth that is threatening to affect the visual axis via astigmatism or opacity
- Restriction of eye movement
- Significant cosmetic impact or intractable irritation
Question 1 |
Chronic use of contact lenses Hint: Not a significant risk factor for pterygium. | |
Frequent use of ocular steroids Hint: More associated with cataract and glaucoma. | |
History of recurrent corneal infections Hint: Not directly linked to pterygium development. | |
Genetic predisposition Hint: While there may be a genetic component, UV light exposure is a more significant risk factor. | |
Long-term exposure to ultraviolet (UV) light |
Question 2 |
Observation and artificial tears | |
Topical antiviral therapy Hint: This is used for viral infections of the eye, such as herpes simplex keratitis, and is not indicated for a pterygium. | |
Surgical excision Hint: Surgery is considered when the pterygium is actively growing and threatening vision, or causing significant discomfort or astigmatism, not for stable, asymptomatic cases. | |
Topical corticosteroid therapy Hint: While steroids can reduce inflammation, they are not typically used for pterygium management due to potential side effects and are not indicated unless there is significant inflammation. | |
Systemic antibiotic treatment Hint: This is not indicated for pterygium as it is not an infectious condition. |
Question 3 |
Observation and artificial tears Hint: Appropriate for asymptomatic or mildly symptomatic cases. | |
Topical corticosteroids Hint: May be used to reduce inflammation but do not address the growth. | |
Surgical excision | |
Radiation therapy Hint: Not a standard treatment for pterygium. | |
Topical antihistamines Hint: Used for allergic conjunctivitis, not pterygium. |
List |
References: Merck Manual · UpToDate